Operating Lease, Right-of-Use Asset of Kyverna Therapeutics, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kyverna Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Kyverna Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,317,000, a 40% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kyverna Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,317,000 -$2,836,000 -40% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,049,000 -$2,776,000 -35% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $5,764,000 -$2,722,000 -32% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $6,468,000 -$26,000 -0.4% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $7,153,000 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $7,825,000 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $8,486,000 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $6,494,000 31 Dec 2023 10-K 27 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.